Testicular damage is one of the most deleterious effects whenever cisplatin (CIS) is employed in cancer chemotherapy. Oxidative stress has been proven to be involved in CIS induced toxicity. Thus, the current study explored the possible protective effect of L-carnitine (L-CAR) against cisplatin-induced testicular damage in rats. L-carnitine (500 mg/kg/day; i.p.) was injected for 15 days, whereas cisplatin (10 mg/kg; i.p.) was injected as a single dose at the 12 th day to induce testicular damage in adult male Sprague-Dawley rats. In the current study, CIS reduced the reproductive organs weight, sperm count, sperm motility and serum testosterone level beside a marked increase in the incidence of sperm abnormalities. In addition, it significantly increased malondialdehyde (MDA) and nitric oxide (NO) along with a marked decrease in testis reduced glutathione (GSH) content and superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) activities. At the same time, CIS administration resulted in marked elevation in tumor necrosis factor-α (TNF-α) production and nuclear factorkabba B (NF-κB) expression. These results were confirmed by histopathological examination. Treatment with L-CAR markedly attenuated cisplatin-induced injury by suppression of oxidative/nitrosative stress and inflammation, amendment of antioxidant defenses, as well as improvement of steroidogenesis, spermatogenesis and testicular histological features. This study suggests a novel therapeutic application for L-carnitine as a protective agent against cisplatininduced testicular toxicity through its promising anti-inflammatory and antioxidant capacities.
L-carnitine has also been shown to play an important role in the control of the male reproductive system and normal function of the testis, where it is highly concentrated in the male reproductive system, especially in the epididymis (Ng et al., 2004) . It acts on male gamete maturation and seems to have a key role in: providing readily available energy for sperm motility In view of these considerations, the functional health effect of L-carnitine in protecting against cisplatin toxicity could be of current interest. Therefore, the aim of this study was to evaluate the potential protective effects of L-carnitine against testicular toxicity induced by cisplatin in male rats by the assessment of hormonal and spermatological changes, oxidative stress parameters, inflammatory markers, and the testicular histopathological alterations.
Material and methods

Drugs and Chemicals
Cisplatin (10mg/10ml) was purchased from Mylan, Saint-Priest, France. L-carnitine was purchased from Arab company for pharmaceutical and medicinal plant (MEPACO), Cairo, Egypt. All other chemicals were of the highest purity and analytical grade.
Animals
Male adult Sprague-Dawley rats 250-280 g, were obtained from the breeding colony of the National Organization for Drug Control and Research (NODCAR), Giza, Egypt. Animals were accommodated under controlled environmental conditions (23±2°C temperature, 60±10% humidity, 12/12 h light/dark cycle) and were allowed standard chow diet and water ad libitum. The investigation complies with the Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85-23, revised 1996) and was approved by the Ethics Committee of Faculty of Pharmacy, Cairo University, Cairo, Egypt (Permit Number: PT 922).
Experimental design and protocol
Forty male rats were randomly divided into four groups (n= 10 rats per each). Group I: animals were fed with normal diet for 15 days (Control). Group II: animals were treated with Lcarnitine (500 mg/kg/day; i.p.) for 15 days (Cayir et al., 2009). Group III: animals were fed with normal diet for 15 days and received a single intraperitoneal dose of cisplatin (10 mg/kg) on 12 th day (Longo et al., 2011). Group IV: animals were treated with L-carnitine (500 mg/kg/day; i.p.) for 15 days as well as a single intraperitoneal dose of cisplatin (10 mg/kg) on 12 th day. Animals were weighed and scarified by decapitation 24 hours after the last treatment for collection of serum and for examination of the semen parameter. Testis and other reproductive accessory organs were immediately removed and cleaned from the adhering tissue and weighed.
Analysis of blood samples
Blood samples were collected from the retro-orbital sinus (Cocchetto and Bjornsson, 1983) of each rat, and the sera were separated and kept at -80C till determination of testosterone level. Serum level of testosterone was assayed using Rat Testosterone EIA kit (Enzo life sciences, San Diego, USA) according to the manufacturer procedure.
Analysis of tissue samples
The testis were removed and cleaned from the adhering tissue and weighed. The right testis was decapsulated and homogenized in ice-cold 0.05 M potassium phosphate buffer (pH 7.4) to give 10% homogenate and samples were stored at -80C till estimations of the biochemical parameters. The left testis was preserved in 10% formalin for histopathological and immunohistochemical examination.
Determination of testicular oxidative stress biomarkers
Malondialdahyde (MDA), as an index for lipid peroxidation, was determined in testicular homogenate by detecting the absorbance of thiobarbituric acid reactive substances at 535 nm (Erdincler et al., 1997). Another aliquot of the testicular homogenate was mixed with 5% sulfosalicylic acid and centrifuged at 1000 x g for 15 min. The resulting protein-free supernatant was used for the determination of reduced glutathione (GSH) according to the method described by Beutler et al. (1963) . The third proportion of the testicular homogenate was centrifuged at 4000 rpm for 15 minutes at 4 °C and the clear supernatant was used for determination of the testicular superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX) activities and nitric oxide (NO) content using the Biodiagnostic Colorimetric Kits (Cairo, Egypt) according to the manufacturer's instruction.
Determination of testicular tumor necrosis factor-alpha (TNF-α) content
Testicular homogenate was centrifuged at 4000 rpm for 15 minutes at 4 °C and the resulting supernatant was used for the determination of TNF-α using Rat TNF-α Elisa reagent kit (Enzo life sciences, San Diego, USA) according to the manufacturer procedure.
Evaluation of the sperm parameters
The epididimal content of each rat was obtained after cutting the tail of epididymis and squeezing it gently in sterile clean watch glass and examined according to the technique adopted by Bearden and fluquary (1980) for the estimation of sperm count, motility and abnormalities.
Histological study
The fixed testis was processed for paraffin embedding and 4 μm sections were prepared. Testicular sections were stained with haematoxylin and eosin (H&E) and examined using a light microscope (40×). Qualitative histopathological damage in the seminiferous tubules was graded according to the severity of degenerative findings: (−) no obvious damage, (+) fewer than 25% of seminiferous tubules affected (mild), (++) 25-50% of seminiferous tubules affected (moderate), and (+++) over 50% of seminiferous tubules affected (severe) (Rezvanfar et al., 2013). Histopathological examination of testes was interpreted by an experienced observer who was blind to the sample identity to avoid any bias.
Testicular NF-κB immunohistochemical examination
Paraffinized testicular sections from control and the various treated groups were deparaffinized in xylene, dehydrated in graded alcohol, and finally hydrated in water. Antigen unmasking was performed by incubating the sections for 20 min in citrate buffer (Thermo Fisher Scientific, Fremont, CA; pH 6.0) at the boiling point then cooled. Sections were then incubated overnight at 4°C with the rabbit polyclonal anti-NF-κB primary antibody (1:200; Invitrogen, Carlsbad, CA). After washing with phosphate-buffered saline (PBS), the slides were incubated for 30 min at 37°C with the biotinylated secondary antibody then with the Vector Elite ABC kit (Avidin DH and biotinylated horseradish peroxidase H reagents; Vector Laboratories Inc., Burlingame, CA). After another wash with PBS, the antibody-biotin-avidin-peroxidase complex was developed using diaminobenzidine tetrahydrochloride (DAB Substrate Kit, Vector Laboratories Inc.). Sections were counterstained with hematoxylin, dehydrated, and cleared in xylene then cover slipped and examined through the light microscope (400×), where the reaction appeared as a brown cytoplasmic reaction.
Statistical analysis
Data were expressed as means ± standard error of the mean (SE). The statistical significance between the means of different groups was analyzed using one way analysis of variance (ANOVA) followed by Tukey-Kramer multiple comparison test. Level of statistical significance was set at p<0.05. Prism computer program (GraphPad software Inc. V5, San Diego, CA, USA) was used to carry out all statistical tests.
Results
There was no change in any of the tested parameters between the control rats and those which received L-carnitine (at the selected dose).
Effects on reproductive organs weights
Cisplatin administration resulted in a significant decrease in body as well as relative reproductive organs weight when compared to control group. Cisplatin decreased body weight to 87.7% of control rats, an effect that was not alleviated by L-carnitine treatment. The relative weights of right and left testis, cauda epididymis, prostate and seminal vesicle were significantly decreased after cisplatin exposure to 82.9%, 85.2%, 76.6%, 73.7% and 80.7 % of the control group; respectively, while all of them were normalized by L-carnitine administration (Table 1) . Table 1 . Effects of L-carnitine on cisplatin-induced alterations in body and reproductive organs weight in rats.
Note: Values are expressed as mean ± SEM of 10 animals in each group. * vs control, @ vs CIS (one-way ANOVA followed by Tukey-Kramer multiple comparisons test; p<0.05). CIS, cisplatin; L-CAR, L-carnitine; BW, body weight. Table 2 showed a substantial decrease in sperm count and motility % almost by half and an increase in sperm abnormalities % to 2.7 folds with cisplatin administration compared to the corresponding values of the control group. Furthermore, serum testosterone level was markedly declined to 73.3% of the control group. Treatment with L-carnitine completely alleviated the changes induced by cisplatin with restoration of the normal values of all sperm parameters and serum testosterone level. 
Effects on sperm parameters and serum testosterone level
Effects on the testicular TNF-α and the oxidative stress biomarkers levels
Cisplatin injection markedly amplified testicular MDA, NO, and TNF-α contents by 3.6, 1.6 and 5.2 folds, respectively; whereas it resulted in a decline in testicular GSH content along with SOD, CAT and GPx activities by 60.47%, 56.41%, 47.10% and 65.90%, respectively as compared to the control group. L-carnitine resulted in a significant increase in SOD activity and GSH content to 191% and 166%, respectively; when compared to cisplatin treated group, and caused restoration of the normal values of MDA, NO, TNF-α, CAT and GPx (Fig. 1-3) . 
Effects on testicular NF-κB expression
Sections in testis of cisplatin treated rats displayed an enhanced NF-κB protein expression confined within the interstitial stroma adjacent to the basement membrane of degenerated tubules (Fig. 4C & Table 3 ), an effect that alleviated by management with Lcarnitine (Fig. 4D & Table 3 ). 
Effects on hematoxylin and eosin sections
Testicular sections of the cisplatin group revealed atypical morphological features manifested as massive degeneration in the seminiferous tubules, shrinkage in germ cell layers and disruption of spermatogenesis, interstitial edema, congestion in blood vessels and replacement of the interstitial stroma with homogeneous eosinophilic material (Fig. 5C & Table  4 ). L-carnitine treatment normalized these histological abnormalities and amended spermatogenesis, though a slight some homogenous eosinophilic material in the interstitial stroma (t) was still observed (Fig. 5D & Table 4 ). 
Discussion
The human testis is a known target organ for injury resulting from exposure to cisplatin. Short-and long-term cisplatin treatments result in germinal epithelial damage, sperm dysfunction and germ cell apoptosis in animals and humans (Cherry et al., 2004; Boekelheide, 2005) . Many studies have shown that cisplatin impaired rat testicular structure through inflicting oxidative stress and inducing cell apoptosis (Amin and Hamza, 2006; Amin et al., 2008) . Thus, it seems imperative to search for agents that can protect against testicular toxicity whenever cisplatin chemotherapy is employed.
The present study highlights the protective actions of L-carnitine against cisplatininduced testicular toxicity in rats as verified by the restoration of testicular architecture, enhancement of steroidogenesis, preservation of spermatogenesis, modulation of the inflammatory reaction along with suppression of oxidative/nitrosative stress.
In the present study, a significant decrease in body and reproductive organs weights accompanied by marked histopathological alterations in the testicular tissue was observed in cisplatin treated rats, findings that are in agreement with previous work (Azu et al., 2010; Salem et al., 2012; Adejuwon et al., 2015) . The reduction in reproductive organs weight is due to marked parenchymal atrophy in germinal cell layers, loss of maturation in the germinal cells and arrested spermatocytes at different stages of division which lead to tubular shrinkage in testicular tissues (Ilbey et al., 2009a; Beytur et al., 2012) . Furthermore, the observed reduction in body weight may be due to malnutrition caused by systemic toxic effect of cisplatin (Salem et al.,  2012) . The histopathological alterations induced by cisplatin, may be explained by the abnormal production of ROS and the imbalance between oxidants and antioxidants in testicular tissue Herein, L-carnitine mostly alleviated the reduction in reproductive organs weight induced by cisplatin and caused a significant rescue of testicular function by preserving the intact seminiferous tubular morphology. Ramadan et al. (2002) stated that pretreatment with Lcarnitine reversed most histopathological changes induced by magnetic field. The results of the current study also are in accordance with the study of Gawish et al. (2011) who showed that Lcarnitine improved varicocele-induced degenerative changes in the ipsilateral testis of albino rats.
Moreover, cisplatin-induced reduction in testosterone level was significantly reverted by L-carnitine administration, which is in accordance with preceding investigations (Dehghani et al., 2013; El-Maddawy, 2014; Ahmed et al., 2014; Ghanbarzadeh et al., 2014) . This remarkable reduction in the hormonal level might be explained by cisplatin-induced severe damages on leydig and sertoli cells resulting from increased generation of free radicals as one of the possible mechanisms (Tousson et al., 2014) . In addition, many reports indicated that cisplatin-induced
changes in testosterone level may occur through interference with Luteinizing hormone (LH) receptor expression and impairment of the cholesterol mobilization to mitochondrial cytochrome P450 thus interfering with the first steps in testosterone production (Silici et al., 2009; Longo et al., 2011; Beytur et al., 2012) .The beneficial effect of L-carnitine on testosterone level may be explained by its anti-oxidative property which prevents oxidative stress induced Leydig cells impairment (Ghanbarzadeh et al., 2014) .
Actually, testosterone is essential for the normal spermatogenesis as well as for the maintenance of normal structure of seminiferous tumbles (Sharpe et al., 1992) .The spermatogenic impairment in cisplatin-treated rats indicated in the present study isn't only the result of the reduced testosterone level; but it may be also due to the formation of free radical products in the testicular tissues as they exert a detrimental effect on spermatogenesis (Ilbey et al., 2009a; Kaya et al., 2015) . The increase in free radical production and the decrease in antioxidant enzymes induced by cisplatin caused a rapid loss of intracellular Adenosine Triphosphate (ATP), leading to loss of sperm motility, axonemal damage and decreased sperm viability (Turk et al., 2008) . In addition, the reduction in sperm motility and increased abnormal sperm rate in cisplatin-treated rats may be caused by lipid peroxidation of unsaturated fatty acids in the sperm plasma membrane resulting in loss of its fluidity and function (Atessahin et al., 2006) . Noteworthy, L-carnitine prevented, to a large extent changes in sperm characteristics observed following cisplatin exposure. These results are in agreement with many reports (Yari et al., 2010; Gawish et al., 2011; Ahmed et al., 2014; Yuncu et al., 2015) which indicated that Lcarnitine enhanced sperm count and motility and reduced sperm abnormalities. Such constructive effects may be attributed to the increased hormonal level, decreased apoptotic cell death and suppressed oxidative stress as well as lipid peroxidation (Ghanbarzadeh et al., 2014; Yuncu et al., 2015) .
In the current study, cisplatin decreased testicular reduced glutathione (GSH) content as well as superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) activities and elevated malondialdehyde (MDA) level, results that in coherence with previous experimental studies ( Amin et al., 2012; Salem et al., 2012; Adejuwon et al., 2015) . The decrease in the activities of these enzymes could be explained either with their consumption during the conversion of free radicals into less harmful or harmless metabolites, or due to the direct inhibitory effect of cisplatin on the enzyme activity (Zhao et al., 2014) . Due to the high concentration of polyunsaturated fatty acids and low antioxidant capacity, testis is one of the major target organs for oxidative stress and peroxidative damage, a process resulting in reduced sperm viability, motility and thus infertility (Aitken and Curry, 2011; Beytur et al., 2012) .
In the present investigation, L-carnitine reduced oxidative stress through attenuation of MDA production and improvement of the antioxidant status in testicular tissues via augmentation of SOD, CAT, GPx and GSH levels. Our results were in harmony with earlier reports showing that L-carnitine attenuated lipid peroxidation and enhanced the antioxidant balance in rat testicular tissues (El-Maddawy, 2014; Ghanbarzadeh et al., 2014; Yuncu et al., 2015) . This was probably due to L-carnitine direct antioxidant effects or the enhanced biosynthesis of GSH and the other antioxidant enzymes (Cayir et al., 2009; Ghanbarzadeh et al., 2014) . In addition, L-carnitine reduces the availability of lipids for peroxidation by transporting fatty acids into the mitochondria for β-oxidation and consequently mitigates the production and accumulation of lipid peroxidation products (Izgut-Uysal et al., 2003; Dokmeci et al., 2005; Derin et al., 2006) .
It is well known that oxidative stress stimulate transcription factors, including NF-κB (Kundu and Surh, 2005) , which is a functional link between oxidative damage and inflammation (Hamza et al., 2016) . The result of the present study revealed that cisplatin promoted the expression of nuclear factor-kappa B (NF-κB) and increased production of tumor necrosis factoralpha (TNF-α) and nitric oxide (NO). Many studies which in accordance with our result showed that cisplatin-induced oxidative stress upregulated the expression of NF-κB, which consecutively increased the transcription of TNF-α and inducible nitric oxide synthase (iNOS) resulting in excessive NO production (Sherif et al., 2014; Hamza et al., 2016) . Indeed, inflammation is considered as one of the important mechanisms by which cisplatin mediates testicular injury (Ilbey et al., 2009b; Hamza et al., 2016) .
The results of the present study, revealed that L-carnitine caused a significant decrease in testicular NF-κB expression and TNF-α and NO production. These effects are in line with previous studies which reported that L-carnitine can block the activation of NF-κB signaling pathway (Arafa, 2008; Zambrano et al., 2013) . In addition, Ahmed et al. (2014) stated that, Lcarnitine exhibited a powerful down-regulation of mRNA expression of TNF-α and this could be explained in part by its antioxidant activities (Thangasamy et al., 2009 ) and also by its glucocorticoid-like effect on the expression of pro-inflammatory cytokines (Schetter et al., 2010) .
Taken together, it can be concluded that treatment with L-carnitine provided significant and comparable protective effects against cisplatin-induced testicular toxicity in rats. The beneficial actions of this agent may be attributed to its capability to scavenge free radicles, augment antioxidants, and deactivate NF-κB signaling pathway. Therefore, we suggest that supplementation with L-carnitine may be beneficial in the clinical treatment of cancer patients with cisplatin while avoiding many of its side effects particularly reproductive system toxicity.
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